Chemomab Therapeutics LTD. (CMMB) — 20-F Filings
All 20-F filings from Chemomab Therapeutics LTD.. Browse 2 Foreign Annual Report reports with AI-powered summaries and risk analysis.
20-F Filings (2)
-
Chemomab Therapeutics Files 20-F, Reports Capital Losses
— Apr 4, 2025 Risk: medium
Chemomab Therapeutics Ltd. filed its 20-F report for the fiscal year ending December 31, 2024. The company, formerly known as Anchiano Therapeutics Ltd. and Bio -
Chemomab Therapeutics Files 20-F for FY2023
— Mar 28, 2024 Risk: medium
Chemomab Therapeutics Ltd. filed its 20-F for the fiscal year ending December 31, 2023. The company, formerly known as Anchiano Therapeutics Ltd. and BioCancell
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX